美国 · 平台与数据 · Stocktwits

ImmunityBio Treats First Patients In Europe With Anktiva Plus BCG – Retail Calls It A ‘Great Opening Act’ For Q3 Earnings

来源：Stocktwits · 美国 9 小时前

ImmunityBio said Accord Healthcare will provide commercial expertise and market access support for Anktiva in Europe.

在 Stocktwits 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stocktwits.com)

推荐阅读

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

The Motley Fool

Why Palantir Technologies Stock Dropped Today

Fairfax Financial (OTCMKTS:FRFHF) Hits New 1-Year High After Strong Earnings

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030